PRINTER'S NO. 2260
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE BILL
No.
1959
Session of
2021
INTRODUCED BY PENNYCUICK, O'MARA, ISAACSON, T. DAVIS,
SCHLOSSBERG, HENNESSEY, LEWIS DELROSSO, GUENST, POLINCHOCK,
DOWLING, HAMM, SANCHEZ, SAPPEY, SIMS, O'NEAL, SHUSTERMAN,
BOBACK, N. NELSON, BERNSTINE, E. NELSON AND McNEILL,
OCTOBER 12, 2021
REFERRED TO COMMITTEE ON HEALTH, OCTOBER 12, 2021
AN ACT
Providing for research and clinical studies of psilocybin, for
duties of Department of Health, for duties of institutional
review boards, for duties of authorized psilocybin
manufacturers, for duties of approved investigators and for
reports.
The General Assembly of the Commonwealth of Pennsylvania
hereby enacts as follows:
Section 1. Short title.
This act shall be known and may be cited as the Public Health
Benefits of Psilocybin Act.
Section 2. Declaration of purpose.
The General Assembly finds and declares as follows:
(1) Our nation is experiencing an unprecedented mental
health crisis.
(2) In 2021, more than 47,000,000 Americans were
suffering from a mental illness, including more than
1,800,000 adults in this Commonwealth, which represents 18%
of this Commonwealth's adult population.
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18